Development of a Risk Prediction Model for Linezolid‐Induced Thrombocytopenia Based on the Machine Learning Algorithm

Documenti analoghi

• Evaluating the Impact of Linezolid Metabolites: PNU‐142300 and PNU‐142586 on the Development of Linezolid‐Induced Thrombocytopenia in Adult Patients
  di: Norihiro Sakurai, et al.
  Pubblicazione: (2025)
• Optimizing Linezolid Dosing in Lung Transplant Recipients: Population Pharmacokinetics, Target Attainment, and Thrombocytopenia Risk Assessment
  di: Dan Zhang, et al.
  Pubblicazione: (2026)
• Construction and Validation of a Predictive Model for the Risk of Anti‐Tuberculosis Drug‐Induced Liver Injury Based on Machine Learning Algorithms
  di: Jingru Cheng, et al.
  Pubblicazione: (2025)
• Linezolid‐induced lactic acidosis in critically ill patients: A multicentre study of incidence, severity and predictors
  di: Lina Naseralallah, et al.
  Pubblicazione: (2026)
• Changing Trajectories of Alanine Aminotransferase and Risk of Antituberculosis Drug‐Induced Liver Injury in Chinese Patients: A Cohort Study
  di: Xinyu Chen, et al.
  Pubblicazione: (2024)